Targeting brain and peripheral plasticity of the lipidome in acute kainic acid-induced epileptic seizures in mice via quantitative mass spectrometry

Xu, 2013, Immune mechanisms in epileptogenesis, Front. Cell. Neurosci., 7, 195, 10.3389/fncel.2013.00195 Savage, 2014, The complexities of epilepsy, Nat. Outlook, 511, S2 Eisenstein, 2014, Unrestrained excitement, Nat. Outlook, 511, S4 Cully, 2014, Illuminated targets, Nat. Outlook, 511, S12 Narain, 2014, Complex expressions, Nat. Outlook, 511, S8 Amini, 2015, A molecular approach to epilepsy management: from current therapeutic methods to preconditioning efforts, Mol. Neurobiol., 52, 492, 10.1007/s12035-014-8876-5 Vezzani, 2013, Epilepsy and brain inflammation, Exp. Neurol., 244, 11, 10.1016/j.expneurol.2011.09.033 Kosicek, 2013, Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers, Int. J. Mol. Sci., 14, 1310, 10.3390/ijms14011310 Tassoni, 2008, The role of eicosanoids in the brain, Asia Pac. J. Clin. Nutr., 17, 220 Farooqui, 2000, Brain cytosolic phospholipase A(2): localization, role, and involvement in neurological diseases, Neuroscientist, 6, 169, 10.1177/107385840000600308 Vercueil, 2006, Epilepsy and neurodegenerative diseases in adults: a clinical review, Epileptic Disord., 8, S44 Yegin, 2002, Secretory phospholipase A(2) and phospholipids in neural membranes in an experimental epilepsy model, Acta Neurol. Scand., 106, 258, 10.1034/j.1600-0404.2002.01238.x Guan, 2006, Non-targeted profiling of lipids during kainate-induced neuronal injury, FASEB J., 20, 1152, 10.1096/fj.05-5362com de Freitas, 2010, Neurochemical changes on oxidative stress in rat hippocampus during acute phase of pilocarpine-induced seizures, Pharmacol. Biochem. Behav., 94, 341, 10.1016/j.pbb.2009.09.015 Katona, 2008, Endocannabinoid signaling as a synaptic circuit breaker in neurological disease, Nat. Med., 14, 923, 10.1038/nm.f.1869 Fezza, 2014, Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting, Mol. Cell. Neurosci., 62, 1, 10.1016/j.mcn.2014.07.003 Guggenhuber, 2010, AAV vector-mediated overexpression of CB1 cannabinoid receptor in pyramidal neurons of the hippocampus protects against seizure-induced excitoxicity, PLoS One, 5, 1, 10.1371/journal.pone.0015707 Monory, 2006, The endocannabinoid system controls key epileptogenic circuits in the hippocampus, Neuron, 51, 455, 10.1016/j.neuron.2006.07.006 Lutz, 2004, On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures, Biochem. Pharmacol., 68, 1691, 10.1016/j.bcp.2004.07.007 Mattace Raso, 2014, Palmitoylethanolamide in CNS health and disease, Pharmacol. Res., 86, 32, 10.1016/j.phrs.2014.05.006 Harizi, 2008, Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology, Trends Mol. Med., 14, 461, 10.1016/j.molmed.2008.08.005 Serrano, 2011, Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus, J. Neurosci., 31, 14850, 10.1523/JNEUROSCI.3922-11.2011 Smith, 1989, The eicosanoids and their biochemical mechanisms of action, Biochem. J., 259, 315, 10.1042/bj2590315 Nomura, 2011, Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation, Science, 334, 809, 10.1126/science.1209200 Vila, 2007, Hydrolysis of prostaglandin glycerol esters by the endocannabinoid-hydrolyzing enzymes, monoacylglycerol lipase and fatty acid amide hydrolase, Biochemistry, 46, 9578, 10.1021/bi7005898 Alhouayek, 2014, COX-2-derived endocannabinoid metabolites as novel inflammatory mediators, Trends Pharmacol. Sci., 35, 284, 10.1016/j.tips.2014.03.001 Sperk, 1994, Kainic acid seizures in the rat, Prog. Neurobiol., 42, 1, 10.1016/0301-0082(94)90019-1 Ben-Ari, 2000, Kainate, a double agent that generates seizures: two decades of progress, Trends Neurosci., 23, 580, 10.1016/S0166-2236(00)01659-3 Matyash, 2008, Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics, J. Lipid Res., 49, 1137, 10.1194/jlr.D700041-JLR200 Schuhmann, 2012, Shotgun lipidomics on a LTQ Orbitrap mass spectrometer by successive switching between acquisition polarity modes, J. Mass Spectrom., 47, 96, 10.1002/jms.2031 Bazan, 1982, Arachidonic acid and arachidonoyl-diglycerols increase in rat cerebrum during bicuculline-induced status epilepticus, Neurochem. Res., 7, 839, 10.1007/BF00965677 Puppolo, 2014, A review of analytical methods for eicosanoids in brain tissue, J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 964, 50, 10.1016/j.jchromb.2014.03.007 Farias, 2008, Formation of eicosanoids, E2/D2 isoprostanes, and docosanoids following decapitation-induced ischemia, measured in high-energy-microwaved rat brain, J. Lipid Res., 49, 1990, 10.1194/jlr.M800200-JLR200 Lerner, 2013, Tricks and tracks in the identification and quantification of endocannabinoids, eLS, 10.1002/9780470015902.a0023407 Bindila, 2016, 1412, 9 Wong, 2014, Simultaneous tissue profiling of eicosanoid and endocannabinoid lipid families in a rat model of osteoarthritis, J. Lipid Res., 55, 1902, 10.1194/jlr.M048694 Lomazzo, 2014, Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain, Neuropsychopharmacology, 40, 1 Wenzel, 2013, Endocannabinoid anandamide mediates hypoxic pulmonary vasoconstriction, Proc. Natl. Acad. Sci., 110, 18710, 10.1073/pnas.1308130110 Bertram, 2013, Neuronal circuits in epilepsy: do they matter?, Exp. Neurol., 244, 67, 10.1016/j.expneurol.2012.01.028 Hanstein, 2008, Transgenic overexpression of corticotropin releasing hormone provides partial protection against neurodegeneration in an in vivo model of acute excitotoxic stress, Neuroscience, 156, 712, 10.1016/j.neuroscience.2008.07.034 Farooqui, 2004, Biochemical aspects of neurodegeneration in human brain: involvement of neural membrane phospholipids and phospholipases A 2, Neurochem. Res., 29, 1961, 10.1007/s11064-004-6871-3 Hansen, 2002, Putative neuroprotective actions of N-acyl-ethanolamines, Pharmacol. Ther., 95, 119, 10.1016/S0163-7258(02)00251-6 Choi, 2013, Lysophospholipids and their receptors in the central nervous system, Biochim. Biophys. Acta, 1831, 20, 10.1016/j.bbalip.2012.07.015 Wang, 2010, Selective neuronal vulnerability to oxidative stress in the brain, Front. Aging Neurosci., 2, 1 Méndez-Armenta, 2014, Oxidative stress associated with neuronal apoptosis in experimental models of epilepsy, Oxidative Med. Cell. Longev., 2014, 10.1155/2014/293689 Kano, 2009, Endocannabinoid-mediated control of synaptic transmission, Physiol. Rev., 89, 309, 10.1152/physrev.00019.2008 Castillo, 2012, Endocannabinoid signaling and synaptic function, Neuron, 76, 70, 10.1016/j.neuron.2012.09.020 Chiarlone, 2014, A restricted population of CB1 cannabinoid receptors with neuroprotective activity, Proc. Natl. Acad. Sci. U. S. A., 1 Bojnik, 2012, Changes in the cannabinoid (CB1) receptor expression level and G-protein activation in kainic acid induced seizures, Epilepsy Res., 99, 64, 10.1016/j.eplepsyres.2011.10.020 Abdullah, 2014, Lipidomic analyses identify injury-specific phospholipid changes 3mo after traumatic brain injury, FASEB J., 28, 5311, 10.1096/fj.14-258228 Ruehle, 2013, Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons: distinctive sufficiency for hippocampus-dependent and amygdala-dependent synaptic and behavioral functions, J. Neurosci., 33, 10264, 10.1523/JNEUROSCI.4171-12.2013 Wallace, 2002, Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity, Eur. J. Pharmacol., 452, 295, 10.1016/S0014-2999(02)02331-2 Guggenhuber, 2015, Impaired 2-AG signaling in hippocampal glutamatergic neurons: aggravation of anxiety-like behavior and unaltered seizure susceptibility, Int. J. Neuropsychopharmacol., 1 Marsicano, 2003, CB1 cannabinoid receptors and on-demand defense against excitotoxicity, Science, 302, 84, 10.1126/science.1088208 Freitas, 2004, Pilocarpine-induced status epilepticus in rats: lipid peroxidation level, nitrite formation, GABAergic and glutamatergic receptor alterations in the hippocampus, striatum and frontal cortex, Pharmacol. Biochem. Behav., 78, 327, 10.1016/j.pbb.2004.04.004 Júnior, 2009, Acute seizure activity promotes lipid peroxidation, increased nitrite levels and adaptive pathways against oxidative stress in the frontal cortex and striatum, Oxidative Med. Cell. Longev., 2, 130, 10.4161/oxim.2.3.8488 Shin, 2011, Role of oxidative stress in epileptic seizures, Neurochem. Int., 59, 122, 10.1016/j.neuint.2011.03.025 Yoshikawa, 2006, Profiling of eicosanoid production in the rat hippocampus during kainic acid-induced seizure: dual phase regulation and differential involvement of COX-1 AND COX-2, J. Biol. Chem., 281, 14663, 10.1074/jbc.M511089200 Takemiya, 2006, Prostaglandin E2 produced by late induced COX-2 stimulates hippocampal neuron loss after seizure in the CA3 region, Neurosci. Res., 56, 103, 10.1016/j.neures.2006.06.003 Takemiya, 2007, Roles of prostaglandin synthesis in excitotoxic brain diseases, Neurochem. Int., 51, 112, 10.1016/j.neuint.2007.05.009 Takemiya, 2011, Endothelial microsomal prostaglandin e synthase-1 facilitates neurotoxicity by elevating astrocytic Ca2+ levels, Neurochem. Int., 58, 489, 10.1016/j.neuint.2011.01.003 Shimada, 2014, Role of inflammatory mediators in the pathogenesis of epilepsy, Mediat. Inflamm., 2014, 10.1155/2014/901902 Lo Verme, 2005, The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide, Mol. Pharmacol., 67, 15, 10.1124/mol.104.006353 Simmet, 1988 Ricciotti, 2011, Prostaglandins and inflammation, Arterioscler. Thromb. Vasc. Biol., 31, 986, 10.1161/ATVBAHA.110.207449 Milatovic, 2002, Involvement of nitric oxide in kainic acid-induced excitotoxicity in rat brain, Brain Res., 957, 330, 10.1016/S0006-8993(02)03669-7 Gluck, 2000, CNS oxidative stress associated with the kainic acid rodent model of experimental epilepsy, Epilepsy Res., 39, 63, 10.1016/S0920-1211(99)00111-4 van Leyen, 2013, Lipoxygenase: an emerging target for stroke therapy, CNS Neurol. Disord. Drug Targets, 12, 191, 10.2174/18715273112119990053 Kwon, 2005, Arachidonic acid induces neuronal death through lipoxygenase and cytochrome P450 rather than cyclooxygenase, J. Neurosci. Res., 81, 73, 10.1002/jnr.20520 Hampson, 2002, 12-Hydroxyeicosatetrenoate (12-HETE) attenuates AMPA receptor-mediated neurotoxicity: evidence for a G-protein-coupled HETE receptor, J. Neurosci., 22, 257, 10.1523/JNEUROSCI.22-01-00257.2002 Kennedy, 2015, Respiratory pathophysiology with seizures and implications for sudden unexpected death in epilepsy, J. Clin. Neurophysiol., 32, 10, 10.1097/WNP.0000000000000142 Ueno, 2005, Pulmonary hypertension during epileptic seizure with evidence of increased angiotensin II in pulmonary artery, Heart Vessel., 20, 37, 10.1007/s00380-004-0764-x Azuma, 2012, Pulmonary hemorrhage induced by epileptic seizure, Heart Lung J. Acute Crit. Care, 41, 290, 10.1016/j.hrtlng.2011.08.003 Skerry, 2001, Glutamate signalling in non-neuronal tissues, Trends Pharmacol. Sci., 22, 174, 10.1016/S0165-6147(00)01642-4 Da Cunha, 2014, Experimental lung injury promotes alterations in energy metabolism and respiratory mechanics in the lungs of rats: prevention by exercise, Mol. Cell. Biochem., 389, 229, 10.1007/s11010-013-1944-8 Lutz, 2015, The endocannabinoid system in guarding against fear, anxiety and stress, Nat. Rev. Neurosci., 16, 705, 10.1038/nrn4036 Popoli, 2012, The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission, Nat. Rev. Neurosci., 13, 22, 10.1038/nrn3138 Romigi, 2010, Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy, Epilepsia, 51, 768, 10.1111/j.1528-1167.2009.02334.x